(Reuters) – Cigna Group’s Express Scripts said on Monday it would add three Humira biosimilars drugs from German drugmaker Boehringer and Swiss company Novartis to its list of preferred drugs.
The biosimilars of AbbVie’s blockbuster arthritis treatment Humira will be included as preferred brands on Express Scripts’s formulary or its drug reimbursement list.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Shinjini Ganguli)
